GBank director equity grant: 173 shares; ownership updated

Rhea-AI Filing Summary

James K. Sims, a director of GBank Financial Holdings Inc. (GBFH), acquired 173 shares of the issuer's common stock on 10/01/2025 as part of the board director compensation plan at a reported price of $39.92 per share. After the reported transaction, the filing shows Mr. Sims beneficially owns 8,935 shares directly (including 3,540 previously reported unvested restricted shares) and is associated with an additional 83,801 shares held jointly with his spouse.

The Form 4 was filed by one reporting person and signed via attorney-in-fact on 10/03/2025. Explanatory notes state the 173 shares were granted under the director compensation plan and clarify the composition of previously reported unvested restricted stock.

Positive

• 173 shares granted under the director compensation plan on 10/01/2025
• Reporting clarifies unvested restricted stock balances: 3,540 and 800 shares
• Director's direct beneficial ownership shown as 8,935 shares

Negative

• None.

Insights

Corporate Governance Expert

Director received equity compensation of 173 shares; holdings clarified.

This Form 4 documents a routine director grant: 173 common shares issued under the company's director compensation plan on 10/01/2025 at $39.92 per share. The filing updates previously reported unvested restricted stock balances to 3,540 and 800 shares respectively.

For investors, this is a standard equity-award disclosure that increases the director's direct beneficial ownership to 8,935 shares and notes joint ownership of 83,801 shares with his spouse. The filing contains no indication of sales, option exercises, or other unusual transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SIMS JAMES K

(Last) (First) (Middle)

9115 WEST RUSSELL ROAD

SUITE 110

(Street)

LAS VEGAS NV 89148

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GBank Financial Holdings Inc. [ GBFH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		173(1)	A	$39.92	8,935(2)	D
Common Stock								83,801(3)	D(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares granted under director compensation plan.

2. Balance has been updated to reflect 3,540 shares of unvested restricted stock previously reported in Table II of the filer's Form 3.

3. Balance has been updated to reflect 800 shares of unvested restricted stock previously reported in Table II of the filer's Form 3.

4. Shares are owned by Reporting Person and his wife, Catherine M. Sims, as joint tenants.

	/s/ Jeffery Whicker, Attorney-In-Fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for GBFH disclose?

The filing shows director James K. Sims was granted 173 common shares on 10/01/2025 at $39.92 per share and updates his beneficial ownership totals.

How many shares does James K. Sims beneficially own after the transaction?

The Form 4 reports 8,935 shares beneficially owned directly after the transaction, plus 83,801 shares owned jointly with his spouse.

Were the 173 shares a purchase or a grant?

The filing states the 173 shares were granted under the company's director compensation plan.

Does the Form 4 show any sales or option exercises by the director?

No. The reported transaction is an acquisition (grant); there are no sales or derivative exercises disclosed.

When was the Form 4 signed and filed?

The signature block shows the form executed by attorney-in-fact on 10/03/2025.